본문 바로가기
KERD
논문KCI 등재

Effects of Methylphenidate on Somatic Symptoms and Brain Functional Connectivity in Adolescents with Attention Deficit Hyperactivity Disorder: A Pilot Study

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Objective: This study aimed to evaluate whether somatic symptoms in adolescents with attention deficit hyperactivity disorder (ADHD) are associated with a dissociative pattern of functional connectivity (FC) within the default mode network (DMN) and whether methylphenidate administration can improve clinical and somatic symptoms. We also evaluated whether the improvement of somatic symptoms is associated with increased FC within the DMN in response to methylphenidate treatment. Methods: Fifteen male adolescents with somatic symptoms of ADHD and 15 male adolescents with ADHD without somatic symptoms were included. At baseline and after 6 months of methylphenidate treatment, all adolescents were asked to complete questionnaires for the Korean version of the Dupaul’s ADHD rating scale, the symptom checklist-90- revised-somatization subscales, the Beck Depression Inventory, and the Beck Anxiety Inventory. Additionally, a resting- state functional magnetic resonance imaging scan was conducted. Results: Methylphenidate treatment improved clinical and somatic symptoms in adolescents with ADHD. In addition, it increased brain FC within the DMN from the posterior cingulate cortex (posterior DMN) to the middle prefrontal cortex (anterior DMN). The improvement of somatic symptoms was associated with FC within the DMN from the posterior cingulate cortex to the middle prefrontal cortex in ADHD adolescents with somatic symptoms. Conclusion: Methylphenidate increased brain FC between the anterior and posterior DMN. The improvement of somatic symptoms in adolescents with ADHD was associated with FC within the DMN. The DMN in adolescents with ADHD seems to be associated with the severity of the clinical and somatic symptoms of ADHD.

Abstract

Objective: This study aimed to evaluate whether somatic symptoms in adolescents with attention deficit hyperactivity disorder (ADHD) are associated with a dissociative pattern of functional connectivity (FC) within the default mode network (DMN) and whether methylphenidate administration can improve clinical and somatic symptoms. We also evaluated whether the improvement of somatic symptoms is associated with increased FC within the DMN in response to methylphenidate treatment. Methods: Fifteen male adolescents with somatic symptoms of ADHD and 15 male adolescents with ADHD without somatic symptoms were included. At baseline and after 6 months of methylphenidate treatment, all adolescents were asked to complete questionnaires for the Korean version of the Dupaul’s ADHD rating scale, the symptom checklist-90- revised-somatization subscales, the Beck Depression Inventory, and the Beck Anxiety Inventory. Additionally, a resting- state functional magnetic resonance imaging scan was conducted. Results: Methylphenidate treatment improved clinical and somatic symptoms in adolescents with ADHD. In addition, it increased brain FC within the DMN from the posterior cingulate cortex (posterior DMN) to the middle prefrontal cortex (anterior DMN). The improvement of somatic symptoms was associated with FC within the DMN from the posterior cingulate cortex to the middle prefrontal cortex in ADHD adolescents with somatic symptoms. Conclusion: Methylphenidate increased brain FC between the anterior and posterior DMN. The improvement of somatic symptoms in adolescents with ADHD was associated with FC within the DMN. The DMN in adolescents with ADHD seems to be associated with the severity of the clinical and somatic symptoms of ADHD.

참고문헌 (54)

  1. Beyens I, "Screen media use and ADHD-related behaviors : four decades of research", Proc Natl Acad Sci U S A, 115, pp.9875~9881 (2018)
  2. Yunhye Oh, "Trait Anxiety as a Mediator of the Association between Attention Deficit Hyperactivity Disorder Symptom Severity and Functional Impairment", Clinical Psychopharmacology and Neuroscience, 16(4), pp.407~414 (2018), 대한정신약물학회[DOI]
  3. Secnik K, "Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder", Pharmacoeconomics, 23, pp.93~102 (2005)
  4. Egger HL, "Somatic complaints and psychopathology in children and adolescents : stomach aches, musculoskeletal pains, and headaches", J Am Acad Child Adolesc Psychiatry, 38, pp.852~860 (1999)
  5. Fridh M, "Subjective health complaints and exposure to peer victimization among disabled and non-disabled adolescents : a population-based study in Sweden", Scand J Public Health, 46, pp.262~271 (2018)
  6. Kutuk MO, "Migraine and associated comorbidities are three times more frequent in children with ADHD and their mothers", Brain Dev, 40, pp.857~864 (2018)
  7. Scott LD Jr, "Correlates of somatic symptoms among African American males transitioning from a public system of care", Am J Mens Health, 12, pp.274~282 (2018)
  8. Torgersen T, "Optimal management of ADHD in older adults", Neuropsychiatr Dis Treat, 12, pp.79~87 (2016)
  9. McClernon FJ, "Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change : results from a 12-day contingencymanaged abstinence trial", Nicotine Tob Res, 13, pp.784~792 (2011)
  10. Alves PN, "An improved neuroanatomical model of the default-mode network reconciles previous neuroimaging and neuropathological findings", Commun Biol, 2, pp.370~ (2019)
  11. Weissman DH, "The neural bases of momentary lapses in attention", Nat Neurosci, 9, pp.971~978 (2006)
  12. Helps SK, "Altered spontaneous low frequency brain activity in attention deficit", hyperactivity disorder, 2010, pp.1322, 134~143
  13. Liddle EB, "Task-related default mode network modulation and inhibitory control in ADHD : effects of motivation and methylphenidate", J Child Psychol Psychiatry, 52, pp.761~771 (2011)
  14. Supekar K, "Developmental maturation of dynamic causal control signals in higher-order cognition : a neurocognitive network model", PLoS Comput Biol, 8, pp.e1002374~ (2012)
  15. Picon FA, "Methylphenidate alters functional connectivity of default mode network in drug-naive male adults with ADHD", J Atten Disord, 24, pp.447~455 (2020)
  16. Tao J, "Disrupted control-related functional brain networks in drug-naive children with attention-deficit", hyperactivity disorder, 2017, pp.8, 246~
  17. Yoo JH, "Treatment effect of methylphenidate on intrinsic functional brain network in medication-naïve ADHD children : a multivariate analysis", Brain Imaging Behav, 12, pp.518~531 (2018)
  18. Su Q, "Dissociation of regional activity in default mode network in medicationnaive, first-episode somatization disorder", PLoS One, 9, pp.e99273~ (2014)
  19. Wei S, "Abnormal default-mode network homogeneity and its correlations with personality in drug-naive somatization disorder at rest", J Affect Disord, 193, pp.81~88 (2016)
  20. Loggia ML, "Default mode network connectivity encodes clinical pain : an arterial spin labeling study", Pain, 154, pp.24~33 (2013)
  21. Gündel H, "Altered cerebral response to noxious heat stimulation in patients with somatoform pain disorder", Pain, 137, pp.413~421 (2008)
  22. Ackerman PT, "Methylphenidate effects on cognitive style and reaction time in four groups of children", Psychiatry Res, 7, pp.199~213 (1982)
  23. Volkow ND, "Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain", J Neurosci, 21, pp.RC121~ (2001)
  24. Shih HH, "Comparative efficacy of methylphenidate and atomoxetine on emotional and behavioral problems in youths with attention-deficit", hyperactivity disorder, 2019, pp.29, 9~19
  25. Derogatis LR, "SCL-90-R: administration, scoring & procedures manual-II for the R(evised) version and other instruments of the psychopathology rating scale series" (1992), Clinical Psychometric Research
  26. First M, "User’s guide for the SCID-5-CV structured clinical interview for DSM-5 disorders:clinician version" (2015), American Psychiatric Association
  27. Mak WW, "The phenomenon of somatization among community Chinese Americans", Soc Psychiatry Psychiatr Epidemiol, 39, pp.967~974 (2004)
  28. DuPaul GJ, "ADHD Rating scale- IV: checklists, norms, and clinical interpretation" (1998), Guilford Publications
  29. 소유경, "한국어판 부모, 교사 ADHD 평가 척도의 신뢰도와 타당도 연구", 신경정신의학, 41(2), pp.283~289 (2002), 대한신경정신의학회
  30. Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
  31. Beck AT, "An inventory for measuring clinical anxiety : psychometric properties", J Consult Clin Psychol, 56, pp.893~897 (1988)
  32. Huh HJ, "The relationship between childhood trauma and the severity of adulthood depression and anxiety symptoms in a clinical sample : the mediating role of cognitive emotion regulation strategies", J Affect Disord, 213, pp.44~50 (2017)
  33. Lim YJ, "Korean Anxiety Sensitivity Index-Revised : its factor structure, reliability, and validity in clinical and nonclinical samples", Depress Anxiety, 24, pp.331~341 (2007)
  34. Kwak KH, "Comparison of behavioral changes and brain activity between adolescents with internet gaming disorder and student pro-gamers", Int J Environ Res Public Health, 17, pp.441~ (2020)
  35. Biswal B, "Functional connectivity in the motor cortex of resting human brain using echo-planar MRI", Magn Reson Med, 34, pp.537~541 (1995)
  36. Chai XJ, "Anticorrelations in resting state networks without global signal regression", Neuroimage, 59, pp.1420~1428 (2012)
  37. Greicius MD, "Functional connectivity in the resting brain : a network analysis of the default mode hypothesis", Proc Natl Acad Sci U S A, 100, pp.253~258 (2003)
  38. World Medical Association, "World Medical Association Declaration of Helsinki : ethical principles for medical research involving human subjects", JAMA, 310, pp.2191~2194 (2013)
  39. Golubchik P, "The effect of methylphenidate on anxiety and depression symptoms in patients with Asperger syndrome and comorbid attention deficit", hyperactivity disorder, 2017, pp.32, 289~293
  40. Cao B, "Pharmacological interventions targeting anhedonia in patients with major depressive disorder : a systematic review", Prog Neuropsychopharmacol Biol Psychiatry, 92, pp.109~117 (2019)
  41. Faraone SV, "The pharmacology of amphetamine and methylphenidate : relevance to the neurobiology of attention-deficit", hyperactivity disorder and other psychiatric comorbidities, 2018, pp.87, 255~270
  42. Kritchman M, "Effect of methylphenidate on state anxiety in children with ADHD-A single dose, placebo controlled, crossover study", Front Behav Neurosci, 13, pp.106~ (2019)
  43. Reynolds S, "Sensory overresponsivity and anxiety in children with ADHD", Am J Occup Ther, 63, pp.433~440 (2009)
  44. Shimizu VT, "Sensory processing abilities of children with ADHD", Braz J Phys Ther, 18, pp.343~352 (2014)
  45. Huber C, "Attentional and emotional mechanisms of pain processing and their related factors : a structural equations approach", Pain Res Manag, 15, pp.229~237 (2010)
  46. Lee JS, "Regional cerebral blood flow in children with attention deficit hyperactivity disorder : comparison before and after methylphenidate treatment", Hum Brain Mapp, 24, pp.157~164 (2005)
  47. Drouin C, "Methylphenidate enhances noradrenergic transmission and suppresses mid-and long-latency sensory responses in the primary somatosensory cortex of awake rats", J Neurophysiol, 96, pp.622~632 (2006)
  48. Santos PH, "How does methylphenidate affect default mode network? A systematic review", Rev Neurol, 68, pp.417~425 (2019)
  49. Querne L, "Effects of methylphenidate on defaultmode network", task-positive network synchronization in children with ADHD, 2017, pp.21, 1208~1220
  50. Volkow ND, "Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task", PLoS One, 3, pp.e2017~ (2008)
  51. Kim SM, "Brain functional connectivity in patients with somatic symptom disorder", Psychosom Med, 81, pp.313~318 (2019)
  52. Yan CG, "Reduced default mode network functional connectivity in patients with recurrent major depressive disorder", Proc Natl Acad Sci U S A, 116, pp.9078~9083 (2019)
  53. Xiong N, "Operationalization of diagnostic criteria of DSM-5 somatic symptom disorders", BMC Psychiatry, 17, pp.361~ (2017)
  54. de Vroege L, "Neurocognitive dysfunctioning and the impact of comorbid depression and anxiety in patients with somatic symptom and related disorders : a cross-sectional clinical study", Psychol Med, 48, pp.1803~1813 (2018)

관련 논문AI추천

Brain Network Connectivity and Association with Catechol-O-Methyltransferase Gene Polymorphism in Korean Attention-Deficit Hyperactivity Disorder ChildrenHan Doug Hyun, Kim Yeni, Park Jeong Ha, Son Young Don대한신경정신의학회 · PSYCHIATRY INVESTIGATION2020 · 제17권 제9호Amygdala Nuclei Volumetric Alterations in Adolescent with Attention Deficit Hyperactivity Disorder under Stimulant Medication김지은, 손정우, 이정환, 이현정한국정신병리-진단분류학회 · 정신병리학2023 · 제27권 제2호The Amygdala’s Neurochemical Ratios after 12 Weeks Administration of 20 mg Long-acting Methylphenidate in Children with Attention Deficit and Hyperactivity Disorder: A Pilot Study Using 1H Magnetic Resonance SpectroscopyAnthony Paul Sison Guerrero, Sasanto Wibisono, Sudigdo Sastroasmoro, Tjhin Wiguna대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2014 · 제12권 제2호The Effects of Equine-assisted Activities and Therapy on Resting-state Brain Function in Attention-deficit/Hyperactivity Disorder: A Pilot Study권정이, 김선우, 김연희, 김지원, 송지혜, 신혜연, 오윤혜, 유재현, 이지영, 장병수, 정범석, 정유숙대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2016 · 제14권 제4호Aberrant Effective Connectivity of the Ventral Putamen in Boys With Attention-Deficit/Hyperactivity DisorderChangxiao Kuai, Lei Zhao, Shao-Wei Xue, Yang Xiao, Yunkai Sun, Zhihui Lan대한신경정신의학회 · PSYCHIATRY INVESTIGATION2021 · 제18권 제8호Associations between the Mismatch-negativity Potential and Symptom Severity in Medication-naïve Children and Adolescents with Symptoms of Attention Deficit/hyperactivity Disorder이연정, Ji Sun Kim, Jung Ho Kim, Mi Young Jeong대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2020 · 제18권 제2호

이 간행물의 다른 논문 (20건)